743
Participants
Start Date
October 31, 2009
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2011
Nebivolol
patients administrated Nebivolol according to the prescribing information
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY